Theravance, Inc. (THRX) Misses Q2 Views; Loss Wider than Expected
Tweet
Share
E-mailGet Alerts THRX Hot Sheet
Price: $4.06 --0%
Financial Fact:
Research and development: 286K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 286K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Theravance, Inc. (NASDAQ: THRX) reported Q2 loss of ($0.31), $0.03 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $6.4 million versus the consensus estimate of $8.86 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
